Tecovirimat is safe but ineffective as treatment for clade II mpox NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions.

https://www.nih.gov/news-events/news-releases/tecovirimat-safe-ineffective-treatment-clade-ii-mpox